CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
15mL 0.25% bupivacaine +2 moredrug
Likely dose
15mL 0.25% bupivacainefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03706313
NCT03706313Phase 4Completed

A Comparison of Analgesic Efficacy of Ultrasound-guided Genicular Nerve Block Versus Saline Injection for Total Knee Replacement: a Prospective, Randomized Controlled Trial

Duke University·interventional·Posted Oct 15, 2018·Updated Apr 1, 2021

In Brief

A Phase 4 clinical trial evaluating 15mL 0.25% bupivacaine, Genicular nerve block, and 1 other intervention for Post-operative Pain. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This study seeks to examine the analgesic efficacy of genicular nerve blocks for pain after total knee replacement.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedOct 15, 2018
Enrollment StartJan 15, 2019
Primary CompletionOct 16, 2019
Study CompletionOct 22, 2019
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.7 years ago

Interventions

15mL 0.25% bupivacainedrug

Patients will be randomly assigned to either a genicular nerve block with bupivacaine or saline

Genicular nerve blockprocedure

The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. Color Doppler will be used to identify the arterial structures which serve as landmarks for the corresponding nerves. After skin local anesthetic infiltration, a 10 cm 21G insulated block needle will be inserted and aligned with the ultrasound scanning plane. Once satisfactory position of the needle is confirmed, 5mL of a solution containing 15 ml of 0.25% bupivacaine with 2mg dexamethasone or 5mL saline will be slowly injected. Spread of local anesthetic will be documented adjacent to the target nerve. This procedure will be performed at the site of the three genicular nerves described.

Salinedrug

Patients will be randomly assigned to either a genicular nerve block with bupivacaine or saline